NERVIVE, INC. — Department of Health and Human Services SBIR Phase I: 105

Description

PROJECT SUMMARY Stroke is the world s greatest healthcare burden for which few treatment options are available The long term objective of the applicant Nervive Inc is to bring to market a non invasive medical device the VitalFlow stimulator as an emergency treatment for ischemic stroke The VitalFlow is a novel technology that activates the autonomic components of the facial nerve using pulsed magnetic energy thereby dilating the arteries of the brain and increasing cerebral blood flow CBF Delivery of intravenous tissue plasminogen activator rtPA to the site of an obstructing blood clot will be improved by increasing CBF and endovascular clot retrieval catheter navigation will be facilitated by dilation of the cerebral arteries Thus the VitalFlow stimulator is highly relevant to the mission of the NINDS because it seeks to improve clinical outcomes in stroke patients and reduce the burden of stroke With CREATE Devices grant support we intend to test a clinical prototype VitalFlow stimulator that can be used in the emergency department for the treatment of acute ischemic stroke The following Specific Aims are proposed In Phase I of the CREATE Devices project Nervive will achieve the following Specific Aim Write the Early Feasibility Clinical Study protocol Specific Aim Establish a Quality Control System and freeze VitalFlow device design Specific Aim Complete a Pre IDE meeting with FDA In Phase II of the CREATE Devices project Nervive will achieve the following Specific Aim Complete external performance testing of the VitalFlow stimulator Specific Aim Receive FDA IDE clearance and hospital IRB approval Specific Aim Conduct an Early Feasibility Clinical Study in acute ischemic stroke patients Nervive is pursuing Expedited Access Pre Market Approval PMA regulatory clearance for the VitalFlow In the U S alone the commercial opportunity for the VitalFlow includes the sale of device hardware to hospitals and the sale of consumable components for more than k patient treatments each year PROJECT NARRATIVE Our device the VitalFlow stimulator will increase blood flow to the brain during ischemic stroke thereby preventing injury to the brain that leads to life long disability We now propose to test the VitalFlow device as an emergency treatment for ischemic stroke in the emergency department setting in a small group of patients As a safe effective and simple to use emergency treatment for ischemic stroke the VitalFlow stimulator will have an important impact on patient outcomes and long term disability